Commentary · 8 Oct 2025
Research articlePublished 3 Feb 2016
Outcome of Antenatal Hydronephrosis
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Objective: The aim of this study was to report the outcome of infants with antenatal hydronephrosis. Methods: All patients diagnosed with isolated fetal renal pelvic dilatation (RPD) were prospectively followed between January 2009 and December 2010. The events of interest were the presence of uropathy, requiring surgical intervention, RPD resolution and urinary tract infection (UTI). The diagnosis was established by ultrasound in 49 neonates with antenatal hydronephrosis (ANH) and they were submitted to a specific post-natal evaluative protocol with a follow-up period of 2 years. RPD was classified as mild (5-9.9 mm), moderate (10-14.9 mm) or severe (≥15 mm). Results: A total of 49 patients were included in the analysis; 32 were allocated to the group of non- significant findings (65.3%) and 17 to the group of significant uropathy (34.6%). It was detected that 8 (16.3%) of the group of significant uropathy had ureteropelvic junction obstruction (UPJO), 3 (6.1%) had vesicoureteral reflux (VUR), and 3 (6.1%) had posterior urethral valves (PUV). 9 patients (18.3%) required surgical intervention because of obstructive uropathy. Of the 49 infants with RPD, 20 (40.8%) presented UTI and 32 (65.3%) presented RPD resolution during followup. In our prospective study, it was shown that 81.9% of infants with moderate RPD had UTI during follow-up. Conclusion: Our findings suggested that, in contrast to patients with mild/severe RPD, infants with moderate RPD required a strict clinical surveillance for UTI.
Subjects
Pathology & Lab MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Annals of Clinical and Laboratory Research.
Mini review · 2 Oct 2025
Characteristics and Treatment of Juvenile Myasthenia Gravis
Commentary · 9 Jul 2025
Commentary on Upadacitinib in Difficult-to-Treat Psoriatic Arthritis: Real-World Data from 134 Patients
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAnnals of Clinical and Laboratory Research
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Seçil Conkar”
- BylineArticles whose byline prints “Vüset Memmedov”
- BylineArticles whose byline prints “Sevgi Mir”
